{
    "id": 25768,
    "fullName": "PIK3CG positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "PIK3CG positive indicates the presence of the KITPIK3CG gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 5294,
        "geneSymbol": "PIK3CG",
        "terms": [
            "PIK3CG",
            "p110gamma",
            "p120-PI3K",
            "PI3CG",
            "PI3K",
            "PI3Kgamma",
            "PIK3"
        ]
    },
    "variant": "positive",
    "createDate": "11/29/2016",
    "updateDate": "02/07/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9446,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IPI-549 inhibited tumor growth in cell line xenograft models of colon cancer through reducing the immune-suppressive tumor-associated myeloid cells (PMID: 27828943).",
            "molecularProfile": {
                "id": 26851,
                "profileName": "PIK3CG positive"
            },
            "therapy": {
                "id": 3363,
                "therapyName": "IPI-549",
                "synonyms": null
            },
            "indication": {
                "id": 219,
                "name": "colon cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7194,
                    "pubMedId": 27828943,
                    "title": "Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27828943"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9447,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IPI-549 inhibited tumor growth in cell line xenograft models of melanoma through reducing the immune-suppressive tumor-associated myeloid cells (PMID: 27828943).",
            "molecularProfile": {
                "id": 26851,
                "profileName": "PIK3CG positive"
            },
            "therapy": {
                "id": 3363,
                "therapyName": "IPI-549",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7194,
                    "pubMedId": 27828943,
                    "title": "Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27828943"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9445,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IPI-549 inhibited tumor growth in cell line xenograft models of lung cancer through reducing the immune-suppressive tumor-associated myeloid cells (PMID: 27828943).",
            "molecularProfile": {
                "id": 26851,
                "profileName": "PIK3CG positive"
            },
            "therapy": {
                "id": 3363,
                "therapyName": "IPI-549",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7194,
                    "pubMedId": 27828943,
                    "title": "Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27828943"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9448,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, IPI-549 inhibited tumor growth in cell line xenograft models of breast cancer resistant to immune checkpoint blocking therapy through reducing the immune-suppressive tumor-associated myeloid cells (PMID: 27828943).",
            "molecularProfile": {
                "id": 26851,
                "profileName": "PIK3CG positive"
            },
            "therapy": {
                "id": 3363,
                "therapyName": "IPI-549",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7194,
                    "pubMedId": 27828943,
                    "title": "Overcoming resistance to checkpoint blockade therapy by targeting PI3K\u03b3 in myeloid cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27828943"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26851,
            "profileName": "PIK3CG positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}